Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes

BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) has been shown to be predictive of cardiovascular outcomes in stable coronary artery disease with diabetes. We aimed to assess the relationship between PCSK9 and major adverse cardiovascular events (MACEs) in ST-segment elevation myoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Li, Zhao, Xiaoxiao, Chen, Runzhen, Li, Jiannan, Zhou, Jinying, Liu, Chen, Zhou, Peng, Wang, Ying, Chen, Yi, Zhao, Hanjun, Yan, Hongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123773/
https://www.ncbi.nlm.nih.gov/pubmed/35596184
http://dx.doi.org/10.1186/s12933-022-01519-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123773/
https://www.ncbi.nlm.nih.gov/pubmed/35596184
http://dx.doi.org/10.1186/s12933-022-01519-3

Ejemplares similares